Recombinant Bacillus subtilis Uncharacterized lipoprotein ygaO (ygaO) refers to a protein produced using recombinant DNA technology in Bacillus subtilis, and it is a lipoprotein that has not yet been well-characterized in terms of its function . Lipoproteins are proteins with covalently attached lipid molecules, which can influence their structure, function, and localization . The ygaO protein is found in Bacillus subtilis .
Bacillus subtilis is a Gram-positive, endospore-forming bacterium known for its probiotic properties and its ability to form biofilms . It has a stable heterologous protein expression system and is commonly used as a vehicle for antigen expression . Bacillus subtilis is utilized to display heterologous proteins on the surface of biofilms by introducing coding sequences into the bacterial genome to generate a fusion protein linked to the C terminus of the biofilm matrix protein TasA .
Bacillus subtilis is employed in recombinant protein production due to its generally recognized as safe (GRAS) status, well-understood genetics, and ability to secrete proteins into the extracellular medium, which simplifies purification . Recombinant proteins like ygaO are produced by introducing a gene encoding the protein into Bacillus subtilis, which then expresses the protein .
Vaccine Development: Recombinant Bacillus subtilis spores can be used to immunize animals through oral application .
Biocontrol: Bacillus subtilis strains can produce antifungal lipopeptides, offering a biological control agent against postharvest diseases .
Enzyme Production: Bacillus subtilis is used for the production of various enzymes for industrial applications.
Probiotics: Certain recombinant Bacillus subtilis strains are developed for probiotic applications, enhancing gut health and immunity .
Bacillus subtilis can produce various lipopeptides (LPs), including surfactin, iturin, and fengycin, which have antifungal activity . These LPs are synthesized by non-ribosomal peptide synthetases (NRPSs) .
| Lipopeptide | Molecular Weight (m/z) | Retention Time (min) | Antifungal Activity |
|---|---|---|---|
| Surfactin | 994.64, 1022.68, 1026.62 | 35.47, 43.51 | Yes |
| Iturin | 1043.56 | 31.16 | Yes |
| Fengycin | 1491.85 | 32.12 | Yes |
KEGG: bsu:BSU08890
The ygaO protein (UniProt ID: P97029) is an uncharacterized lipoprotein from Bacillus subtilis strain 168. It has an amino acid sequence of "CWALISYFEASEGIASFFGTKSGGMVFDLNLTPFILFVAASAVYLYLQKKSRPARKQLLLPDEFEEQDEREQMMTAKACRASYIAVYFSLPAAAVLLIFYPLFQSRIPFFPIIIVFIIMIIQHLSYVISFKKNEKNSGAL" with an expression region spanning amino acids 18-157. The protein belongs to the lipoprotein family, suggesting membrane association and potential roles in cellular processes such as nutrient acquisition, signaling, or membrane integrity. Based on structural predictions, it likely contains hydrophobic regions consistent with membrane integration and possible transmembrane domains .
For optimal expression of recombinant ygaO in B. subtilis, several expression systems have demonstrated effectiveness:
IPTG-inducible systems: The pHT43 vector containing a strong promoter derived from the B. subtilis operon groE provides reliable induction. This system has demonstrated yields of 15-20 mg/L for similar proteins .
Self-inducing expression systems: These systems, such as those using the P srfA promoter, allow for automatic induction without human intervention when glucose is added to the medium. These systems have shown up to three-fold increases in protein production compared to standard inducible systems .
Secretion-based expression: Utilizing the general secretion pathway (Sec)-dependent transport system with appropriate signal peptides can facilitate the export of ygaO, potentially simplifying purification processes. Signal peptides must be selected based on protein characteristics for efficient translocation .
The choice between these systems should consider factors such as desired yield, purification strategy, and experimental timeline.
For maintaining structural and functional integrity of recombinant ygaO preparations, implement the following evidence-based storage protocols:
Short-term storage: Store working aliquots at 4°C for up to one week in Tris-based buffer with 50% glycerol .
Long-term storage: Maintain at -20°C, or preferably -80°C for extended stability. Avoid repeated freeze-thaw cycles as they promote protein degradation and aggregation .
Aliquoting strategy: Divide purified protein into single-use aliquots immediately after purification to minimize freeze-thaw cycles.
Buffer optimization: The standard storage buffer containing Tris-based components with 50% glycerol provides optimal stability for this lipoprotein. Consider adding protease inhibitors if proteolytic activity is observed during storage .
Regular quality control assessments using SDS-PAGE or activity assays are recommended to monitor protein integrity over time.
Systematic functional characterization of ygaO should employ a multi-faceted approach:
Comparative genomic analysis: Identify potential orthologs in related species to predict function based on evolutionary conservation patterns.
Interactome mapping: Utilize pull-down assays or bacterial two-hybrid systems to identify protein-protein interactions that may reveal functional associations. This approach has successfully identified roles of other uncharacterized lipoproteins in B. subtilis .
Gene knockout and complementation studies: Generate ygaO deletion mutants to observe phenotypic changes, followed by complementation to confirm specificity. Compare colony morphology, growth characteristics, and stress responses between wild-type and mutant strains .
Transcriptomic analysis: Perform RNA-seq under various conditions to identify co-regulated genes, potentially revealing functional pathways involving ygaO.
Subcellular localization: Use fluorescent protein fusions or immunolocalization to determine precise membrane localization, which can provide functional insights based on spatial organization .
Structural biology approaches: Employ X-ray crystallography or cryo-EM to determine the three-dimensional structure, potentially revealing functional domains not evident from sequence analysis alone.
Each approach should be conducted with appropriate controls, and results should be integrated to build a comprehensive functional profile.
Membrane-associated lipoproteins present unique folding challenges during recombinant expression. Implement these strategies to enhance proper folding:
Chaperone co-expression: B. subtilis contains quality control systems performed by intracellular and extracytoplasmic chaperones. Co-express molecular chaperones like GroEL/ES to facilitate proper folding and prevent aggregation .
Temperature optimization: Lower expression temperatures (16-25°C) slow translation rates, allowing more time for proper folding and reducing inclusion body formation.
Induction optimization: Use lower inducer concentrations with extended expression periods to prevent overwhelming the cell's folding machinery. For IPTG-inducible systems, concentrations between 0.1-0.5 mM have shown optimal results for membrane proteins .
Signal sequence engineering: Optimize the signal sequence for efficient targeting to the secretion pathway. The general secretion pathway (Sec) and the "Twin-arginine" (Tat) translocation system are both viable options for B. subtilis membrane protein expression .
Lipid environment consideration: Supplement expression media with lipids similar to the native membrane composition to facilitate proper integration of hydrophobic domains.
Detergent screening: Identify compatible detergents for extraction and purification that maintain native-like folding. A systematic screen of non-ionic detergents (DDM, LMNG, OG) is recommended for initial optimization.
Monitor folding status using circular dichroism spectroscopy or limited proteolysis assays throughout the optimization process.
When encountering contradictory results in protein-protein interaction studies involving ygaO, implement this systematic resolution framework:
Methodological triangulation: Verify interactions using at least three independent methods (e.g., bacterial two-hybrid, co-immunoprecipitation, and FRET) to establish confidence in observed interactions.
Environmental variable control: Systematically evaluate how different experimental conditions (pH, ionic strength, temperature) affect observed interactions, as membrane protein interactions are often environment-dependent .
Domain-specific interaction mapping: Create truncated versions of ygaO to identify specific interaction domains, resolving contradictions that may arise from multi-domain binding scenarios.
In vivo validation: Confirm interactions observed in vitro through in vivo approaches such as proximity labeling or fluorescence complementation assays under physiologically relevant conditions.
Quantitative binding analysis: Employ surface plasmon resonance or isothermal titration calorimetry to determine binding kinetics and affinities, which can resolve apparent contradictions arising from different interaction strengths.
Computational modeling: Use molecular dynamics simulations to predict interactions and generate testable hypotheses to resolve experimental discrepancies.
Document all experimental conditions meticulously to facilitate troubleshooting and replication, as subtle variations can significantly impact membrane protein interaction studies.
A robust experimental design for studying ygaO functionality requires these essential controls:
Additionally, include time-course analyses to detect temporal aspects of ygaO function, particularly when studying potential signaling or regulatory roles. Document growth phases precisely, as lipoprotein expression and function may vary throughout the bacterial life cycle .
For investigating ygaO's potential role in membrane homeostasis, implement this stepwise experimental design:
Membrane integrity assessment:
Measure membrane permeability using fluorescent dyes (e.g., propidium iodide, SYTOX Green) in wild-type versus ygaO knockout strains.
Conduct membrane fluidity assays using anisotropy measurements with DPH or laurdan probes.
Perform lipid composition analysis via mass spectrometry to identify ygaO-dependent changes in membrane lipid profiles.
Stress resistance evaluation:
Protein localization studies:
Create fluorescent protein fusions to track ygaO localization during membrane stress.
Employ super-resolution microscopy to detect potential ygaO clustering or redistribution.
Use domain-specific antibodies to track potential conformational changes during stress responses.
Interaction partner identification:
Perform cross-linking studies followed by mass spectrometry to identify stress-dependent interaction partners.
Use the bacterial two-hybrid system to detect interactions with known membrane maintenance proteins.
Conduct co-immunoprecipitation under various stress conditions to identify context-specific interactions .
Transcriptional response analysis:
Perform RNA-seq comparing wild-type to ygaO knockout strains during membrane stress.
Quantify expression changes in genes involved in membrane homeostasis and repair pathways.
Validate key findings with quantitative RT-PCR and reporter gene fusions.
Include appropriate controls for each experimental approach and ensure biological and technical replicates for statistical validity.
Selecting the optimal expression region for recombinant ygaO production requires careful consideration of several factors:
Signal sequence evaluation: The native ygaO contains a signal sequence necessary for proper membrane localization. When designing expression constructs, determine whether to include or exclude this sequence based on desired localization (cytoplasmic, membrane-bound, or secreted). For membrane-associated studies, retain amino acids 1-17 as they likely contain targeting information .
Functional domain preservation: The reported expression region (amino acids 18-157) appears to capture the functional core of the protein. Extending this region may incorporate additional structural elements that enhance stability or function. Conduct a systematic truncation analysis to identify the minimal functional unit .
Hydrophobicity analysis: Perform computational analysis of hydrophobic regions that may cause folding challenges or aggregation. Tools like Kyte-Doolittle plots can identify problematic segments that might benefit from optimization or solubility-enhancing tags.
Post-translational modification sites: Analyze the sequence for potential lipidation sites, particularly the N-terminal cysteine at position 18 that serves as the lipidation anchor. Include this residue if studying native lipoprotein characteristics or exclude it for soluble protein studies .
Fusion tag positioning: When incorporating affinity or solubility tags, consider their impact on protein folding and function. N-terminal tags may interfere with signal sequence processing, while C-terminal tags could disrupt membrane interaction domains.
Expression system compatibility: Different expression regions may perform differently in various B. subtilis expression systems. The general secretion pathway (Sec) typically requires unfolded substrates, while the Twin-arginine translocation (Tat) system transports folded proteins .
Conduct pilot expression studies with multiple constructs varying in their expression regions to identify optimal configurations before scaling up production.
When confronted with conflicting data on ygaO structure-function relationships, implement this interpretive framework:
Methodological assessment: Evaluate whether conflicts arise from different experimental approaches. For example, in vitro binding assays may yield different results than in vivo functional studies due to the absence of the native membrane environment .
Context-dependent functionality: Consider whether ygaO exhibits different functions under various conditions. Analyze data separately for different growth phases, stress conditions, and nutritional states before attempting integration .
Multifunctional protein hypothesis: Test whether apparent contradictions result from ygaO serving multiple distinct roles. Many bacterial lipoproteins have context-dependent functions that may appear contradictory when viewed in isolation.
Dominant-negative effects: Assess whether overexpression studies might produce conflicting results due to dominant-negative effects that do not reflect native function. Compare results from complementation studies versus overexpression systems .
Strain-specific variations: Determine if conflicts stem from strain differences by testing identical constructs in multiple B. subtilis backgrounds. Even closely related strains can show different lipoprotein functionality.
Data transformation and normalization: Reevaluate raw data using alternative normalization methods to determine if conflicts arise from data processing rather than biological differences.
Create a comprehensive matrix documenting experimental conditions, strains, constructs, and outcomes to systematically identify patterns in seemingly contradictory results. This approach often reveals conditional factors explaining apparent discrepancies.
Select statistical methods based on the specific experimental design and data characteristics in ygaO studies:
For all analyses, validate statistical assumptions, report variability measures (standard deviation or standard error), and provide clear justification for the chosen statistical approaches. Consider consulting with a biostatistician for complex experimental designs or datasets.
Integrating structural predictions with experimental data requires a systematic approach:
This integrated approach creates a more robust understanding than either computational prediction or experimental data alone and helps direct future research efforts toward the most promising hypotheses.
For structural studies requiring stable, well-folded recombinant ygaO, implement these bioengineering strategies:
Codon optimization:
Analyze the ygaO coding sequence for rare codons in B. subtilis.
Optimize codon usage while maintaining mRNA secondary structure to enhance translation efficiency.
Incorporate strategic silent mutations to remove internal regulatory elements that might reduce expression.
Fusion partner selection:
Sequence engineering:
Identify and neutralize aggregation-prone regions through point mutations.
Introduce disulfide bonds to stabilize tertiary structure based on computational predictions.
Consider surface entropy reduction mutations to enhance crystallization propensity.
Expression conditions optimization:
Membrane mimetic selection:
Screen detergents, nanodiscs, and lipid cubic phase formulations for optimal stability.
Consider amphipols or styrene-maleic acid copolymer lipid particles (SMALPs) for native-like membrane environments.
Evaluate protein stability in each membrane mimetic using thermal shift assays and activity measurements.
Implement these strategies iteratively, with small-scale expression and stability screening before scaling up to production levels required for structural studies.
To delineate direct versus indirect effects of ygaO on cellular processes, implement this experimental framework:
Temporal resolution studies:
Utilize inducible expression systems with tight regulation to track the sequence of cellular changes following ygaO induction.
Implement time-course transcriptomics and proteomics to identify primary versus secondary response waves.
Employ pulse-chase experiments to distinguish immediate versus delayed effects .
Biochemical validation:
Conduct in vitro reconstitution experiments with purified components to demonstrate direct interactions.
Perform enzyme kinetics studies to establish direct enzymatic or regulatory roles.
Use surface plasmon resonance or microscale thermophoresis to quantify binding affinities between ygaO and potential direct targets.
Spatial correlation analysis:
Genetic interaction mapping:
Create a library of double mutants (ygaO plus potential interaction partners).
Analyze epistatic relationships to position ygaO within cellular pathways.
Employ synthetic genetic array analysis to systematically map genetic interactions.
Selective inhibition approaches:
Develop specific inhibitors or nanobodies targeting ygaO.
Assess rapid effects following acute inhibition versus chronic depletion.
Compare inhibitor studies with genetic knockout results to distinguish adaptive responses.
Computational network analysis:
Build directed interaction networks incorporating temporal and spatial data.
Apply causal inference algorithms to differentiate direct from indirect relationships.
Validate computational predictions with targeted experiments.
Document all observations in a standardized framework that explicitly categorizes effects as direct (supported by biochemical evidence) or indirect (downstream consequences) to maintain clarity in interpretation.
Several cutting-edge technologies offer significant potential for advancing ygaO functional characterization:
Cryo-electron tomography:
AlphaFold2 and integrated structural prediction:
Recent advances in AI-based structure prediction can generate high-confidence models even for proteins like ygaO with limited homology to characterized proteins.
Integration with experimental data (crosslinking-mass spectrometry, hydrogen-deuterium exchange) can produce hybrid models of unprecedented accuracy.
Single-molecule tracking:
CRISPRi transcriptional modulation:
Allows precise, titratable control of ygaO expression levels without complete knockout.
Enables dose-response studies to identify threshold effects and quantitative relationships.
Facilitates temporal control for studying acute versus chronic effects of ygaO depletion.
Proximity-dependent biotinylation:
TurboID or miniTurbo fusion proteins can identify transient interaction partners that might be missed by traditional approaches.
Provides temporal resolution of the ygaO interactome under different conditions.
Captures weak or context-dependent interactions difficult to detect with conventional methods.
Native mass spectrometry:
Preserves non-covalent interactions during analysis of membrane protein complexes.
Determines stoichiometry and composition of intact ygaO-containing complexes.
Identifies lipid preferences and sterol interactions that may regulate function.
These technologies, particularly when applied in complementary combinations, offer promising avenues for resolving the functional puzzle of this uncharacterized lipoprotein.
A comprehensive study investigating ygaO's role in stress responses should incorporate these integrated experimental approaches:
Stress response profiling:
Subject wild-type and ΔygaO strains to a standardized panel of stressors (oxidative, osmotic, pH, temperature, antimicrobial peptides).
Implement high-throughput phenotypic characterization using microplate growth kinetics.
Quantify survival rates, lag phases, and growth rates under each condition .
Stress-dependent expression analysis:
Create a ygaO promoter-reporter fusion to monitor expression levels under various stresses.
Perform qRT-PCR and Western blot analyses to correlate transcriptional and translational responses.
Identify stress conditions that specifically modulate ygaO expression.
Localization dynamics:
Interactome mapping:
Implement BioID or APEX2 proximity labeling under both normal and stress conditions.
Conduct differential interactome analysis to identify stress-specific interaction partners.
Validate key interactions through co-immunoprecipitation and FRET studies.
Membrane property assessment:
Measure membrane fluidity, permeability, and potential under stress conditions.
Compare lipid composition changes in response to stress between wild-type and ΔygaO strains.
Assess membrane restoration kinetics following stress removal.
Multi-omics integration:
Perform integrated transcriptomic, proteomic, and metabolomic analyses under selected stress conditions.
Apply network analysis to position ygaO within stress response pathways.
Identify metabolic shifts potentially mediated by ygaO during stress adaptation.
Comparative analysis across Bacillus species:
Extend key experiments to other Bacillus species containing ygaO homologs.
Determine conservation of stress response functions across the genus.
Identify species-specific adaptations that may reveal evolutionary pressure points.
This comprehensive approach would provide a holistic understanding of ygaO's role in stress responses while generating testable hypotheses for more detailed mechanistic studies.